PLUS THERAPEUTICS, INC. — Director's Dealing 2014

Jan 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-01-01

Reporting Person: HOLMES E CARMACK (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-01	Restricted Stock Award (Common Stock)	A	10550	—	Acquired	10550	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-01	Non-Qualified Stock Option (Right to Buy)	$2.57	A	16030	Acquired	2024-01-01	Common Stock (16030)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6100	Direct
Common Stock	37401	Indirect

Footnotes

F1: The Restricted Stock Award vests in full on January 2, 2015, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: These shares are held of record by E. Carmack Holmes & Carolyn K Holmes TTEE, Holmes Living Trust DD 05/15/92.

F3: The stock options vest 1/24th per month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.